Human Volunteers
Conditions
Keywords
Human volunteers
Brief summary
Muscular compartment syndrome (MCS) is consecutive to an increase in intramuscular compartment pressures, and is a rare but serious postoperative complication. The INVOS (In Vivo Optical Spectroscopy) monitors tissular oxygenation continuously and non-invasively. The objective is to develop a model mimicking the physiopathology of MCS to assess the interest of the INVOS in this case.
Detailed description
After inflation of a tourniquet (pressure equal to the mean arterial pressure, we will obtain a model of slight venous congestion and arterial hypoperfusion. A comparison will be made between INVOS monitoring, sensory deficits, pain, electromyography and invasive pressure.
Interventions
Inflation of a tourniquet (pressure equal to the mean arterial pressure) obtaining a model of slight venous congestion and arterial hypoperfusion
Near Infraread spectroscopy, non invasive
Electromyography, non invasive
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy volunteers * \>18yr * Informed consent * Male
Exclusion criteria
* Neuropathies * Vascular pathology * Actual pain * Anti-platelet or anticoagulant therapy * Ipsilateral history of fracture
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison Between INVOS Monitoring and Electromyography | 45 minutes | A comparison will be made between the INVOS monitoring and non invasive (transcutaneous) EMG monitoring (AP Block), to determine the accuracy of the INVOS monitoring to predict AP block. Measures were: \[mean (SD)\] INVOS (in %) value at baseline and at the time of the block |
| Intracompartmental Pressure (ICP) | 45 minutes | \[mean (SD)\] ICP (in mmHg), value at baseline and at the time of the block |
Countries
Belgium
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Tourniquet No adverse event | 10 |
| Total | 10 |
Baseline characteristics
| Characteristic | Tourniquet |
|---|---|
| Age, Customized age | 33 years STANDARD_DEVIATION 4 |
| Sex: Female, Male Female | 0 Participants |
| Sex: Female, Male Male | 10 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | — / — |
| other Total, other adverse events | 0 / 10 |
| serious Total, serious adverse events | 0 / 10 |
Outcome results
Comparison Between INVOS Monitoring and Electromyography
A comparison will be made between the INVOS monitoring and non invasive (transcutaneous) EMG monitoring (AP Block), to determine the accuracy of the INVOS monitoring to predict AP block. Measures were: \[mean (SD)\] INVOS (in %) value at baseline and at the time of the block
Time frame: 45 minutes
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Tourniquet | Comparison Between INVOS Monitoring and Electromyography | INVOS (Baseline) | 73 % of StcO2 | Standard Deviation 9 |
| Tourniquet | Comparison Between INVOS Monitoring and Electromyography | INVOS (At time of the block) | 46 % of StcO2 | Standard Deviation 11 |
Intracompartmental Pressure (ICP)
\[mean (SD)\] ICP (in mmHg), value at baseline and at the time of the block
Time frame: 45 minutes
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Tourniquet | Intracompartmental Pressure (ICP) | ICP (Baseline) | 17 mmHg | Standard Deviation 9 |
| Tourniquet | Intracompartmental Pressure (ICP) | ICP (At time of the block) | 70 mmHg | Standard Deviation 6 |